Matches in DBpedia 2014 for { <http://dbpedia.org/resource/AZD5423> ?p ?o. }
Showing items 1 to 32 of
32
with 100 items per page.
- AZD5423 abstract "AZD5423 is a phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.".
- AZD5423 iupacName "2,2,2-Trifluoro-N-[(1R,2S)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-(3-methoxyphenyl)-2-propanyl]acetamide".
- AZD5423 thumbnail AZD5423_structure.svg?width=300.
- AZD5423 wikiPageID "39105397".
- AZD5423 wikiPageRevisionID "578008646".
- AZD5423 c "25".
- AZD5423 chemspiderid "28536140".
- AZD5423 f "4".
- AZD5423 h "21".
- AZD5423 inchi "1".
- AZD5423 inchikey "FCNQMDSJHADDFT-WNSKOXEYBZ".
- AZD5423 iupacName "222".
- AZD5423 molecularWeight "487.446".
- AZD5423 n "3".
- AZD5423 o "3".
- AZD5423 smiles "C[C@@H]NCCF".
- AZD5423 stdinchi "1".
- AZD5423 stdinchikey "FCNQMDSJHADDFT-WNSKOXEYSA-N".
- AZD5423 subject Category:Ethers.
- AZD5423 subject Category:Indazoles.
- AZD5423 subject Category:Organofluorides.
- AZD5423 subject Category:Respiratory_agents.
- AZD5423 type Drug.
- AZD5423 type FunctionalSubstance.
- AZD5423 comment "AZD5423 is a phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.".
- AZD5423 label "AZD5423".
- AZD5423 sameAs m.0t53x0f.
- AZD5423 sameAs Q15408423.
- AZD5423 sameAs Q15408423.
- AZD5423 wasDerivedFrom AZD5423?oldid=578008646.
- AZD5423 depiction AZD5423_structure.svg.
- AZD5423 isPrimaryTopicOf AZD5423.